Tuberculosis and Other Opportunistic Infections

Guidelines for the Prevention and Treatment of Opportunistic Infections in HIV-Infected Adults and Adolescents

  • Source: Centers for Disease Control and Prevention, National Institutes of Health, HIV Medicine Association of the Infectious Diseases Society of America

  • Publication Date: 7/22/21

Clinical Practice Guideline by the Infectious Diseases Society of America (IDSA) and Society for Healthcare Epidemiology of America (SHEA): 2021 Focused Update Guidelines on Management of Clostridioides difficile Infection in Adults

  • Source: Society for Healthcare Epidemiology of America (SHEA) and the Infectious Diseases Society of America (IDSA)

  • Publication Date: 6/14/21

ACG Clinical Guidelines: Prevention and Treatment of Clostridiodes difficile Infections

  • Source: American College of Gastroenterology

  • Publication Date: 5/18/21

Guidelines for the Prevention and Treatment of Opportunistic Infections in HIV-Exposed and HIV-Infected Children

  • Source: Centers for Disease Control and Prevention, the National Institutes of Health, the HIV Medicine Association of the Infectious Diseases Society of America, and the Pediatric Infectious Diseases Society

  • Publication Date: 12/9/19

Compendium of WHO guidelines and associated standards: ensuring optimum delivery of the cascade of care for patients with tuberculosis

  • Source: World Health Organization

  • Publication Date: 6/1/18

Treatment of Tuberculosis

  • Source: American Thoracic Society, Centers for Disease Control and Prevention, and the Infectious Diseases Society of America

  • Publication Date: 10/1/16

Prevention and treatment of opportunistic infections and other coinfections in HIV-infected patients: May2015

  • Source: AIDS Study Group GeSIDA (Grupo de Estudio de Sida)

  • Publication Date: 1/1/16

Practice Guidelines for the Diagnosis and Management of Skin and Soft Tissue Infections: 2014 Update by the Infectious Diseases Society of America

  • Source: Infectious Diseases Society of America

  • Publication Date: 6/18/14

Managing Drug Interactions in the Treatment of HIV-Related Tuberculosis

  • Source: Centers for Disease Control and Prevention

  • Publication Date: 6/1/13

Use of 13-Valent Pneumococcal Conjugate Vaccine and 23-Valent Pneumococcal Polysaccharide Vaccine for Adults With Immunocompromising Conditions: Recommendations of the Advisory Committee on Immunization Practices (ACIP)

  • Source: Centers for Disease Control and Prevention

  • Publication Date: 10/12/12

Rapid Advice: Diagnosis, Prevention and Management of Cryptococcal Disease in HIV –infected Adults, Adolescents and Children

  • Source: World Health Organization

  • Publication Date: 12/1/11

British HIV Association Guidelines for the Treatment of TB/HIV Coinfection

  • Source: British HIV Association

  • Publication Date: 10/1/11

Automated Real-Time Nucleic Acid Amplification Technology for Rapid and Simultaneous Detection of Tuberculosis and Rifampicin Resistance: Xpert MTB/RIF System; 2011

  • Source: World Health Organization

  • Publication Date: 1/1/11

Guidelines for Intensified Tuberculosis Case-Finding and Isoniazid Preventive Therapy for People Living With HIV in Resource-Constrained Settings

  • Source: World Health Organization

  • Publication Date: 12/1/10

Updated Guidelines for Using Interferon Gamma Release Assays to Detect Mycobacterium tuberculosis Infection-United States, 2010

  • Source: Centers for Disease Control and Prevention

  • Publication Date: 6/1/10

Joint WHO/ILO policy guidelines on improving health worker access to prevention, treatment and care services for HIV and TB

  • Source: World Health Organization, International Labor Organization

  • Publication Date: 4/28/10

Clinical practice guidelines for the management of cryptococcal disease: 2010 update by the Infectious Diseases Society of America

  • Source: IDSA

  • Publication Date: 1/1/10

Vancomycin Therapeutic Guidelines: A Summary of Consensus Recommendations from the Infectious Diseases Society of America, the American Society of Health-System Pharmacists, and the Society of Infectious Diseases Pharmacists

  • Source: Infectious Diseases Society of America, the American Society of Health-System Pharmacists, and the Society of Infectious Diseases Pharmacists

  • Publication Date: 8/1/09

Treatment of Clostridium difficile-Associated Disease

  • Source: Leffler DA, Lamont JT

  • Publication Date: 5/1/09

Strategies to Prevent Clostridium difficile Infections in Acute Care Hospitals

  • Source: Society for Healthcare Epidemiology of America/Infectious Diseases Society of America

  • Publication Date: 10/1/08

Policy guidelines for collaborative TB and HIV services for injecting and other drug users: an integrated approach.

  • Source: World Health Organization, United Nations Office on Drugs and Crime, and UNAIDS

  • Publication Date: 1/1/08

Prevention of opportunistic infections in HIV-infected adolescent and adult patients. Guidelines from GESIDA/National AIDS Plan, 2008

  • Source: AIDS Study Group GeSIDA (Grupo de Estudio de Sida)

  • Publication Date: 1/1/08

Infectious Diseases Society of America/American Thoracic Society consensus guidelines on the management of community-acquired pneumonia in adults

  • Source: Infectious Diseases Society of America/American Thoracic Society

  • Publication Date: 3/1/07

Improving the diagnosis and treatment of smear-negative pulmonary and extrapulmonary tuberculosis among adults and adolescents: recommendations for HIV-prevalent and resource-constrained settings

  • Source: World Health Organization

  • Publication Date: 1/1/07

Guidelines on cotrimoxazole prophylaxis for HIV-related infections among children, adolescents and adults

  • Source: World Health Organization

  • Publication Date: 8/7/06

Guidelines for HIV Surveillance Among Tuberculosis Patients

  • Source: World Health Organization/UNAIDS Group on HIV/AIDS/STI Surveillance and the TB/HIV Working Group on the Global Partnership to Stop TB

  • Publication Date: 6/20/04

Update: Adverse Event Data and Revised Recommendations Against Use of Rifampin and Pyrazinamide for Treatment of Latent Tuberculosis Infection

  • Source: American Thoracic Society and the Centers for Disease Control and Prevention

  • Publication Date: 8/8/03

Targeted Tuberculin Testing and Treatment of Latent Tuberculosis Infection

  • Source: US Department of Health and Human Services and the Centers for Disease Control and Prevention

  • Publication Date: 6/9/00

©2020 Clinical Care Options, LLC. All Rights Reserved.

The materials published via inPractice® reflect the views of the reviewers or authors of the material, not those of Clinical Care Options, LLC, the accredited provider, or the companies providing educational grants. The materials may discuss uses and dosages for therapeutic products that have not been approved by the United States Food and Drug Administration. A qualified healthcare professional should be consulted before using any therapeutic product discussed. Readers should verify all information and data before treating patients or using any therapies described in these materials.